Follow the FibroBiologics, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €6.5m. The latest transaction was disclosed on 5 March 2026 (Acquisition). Among the most active insiders: O'HEERON PETE. Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€138,496
8 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate FibroBiologics, Inc. Buy (bullish), based on 2 analysts. Average price target: US$12.50.
58Σ signal
Buys €138,496n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.